Aurigene Discovery Technologies

Aurigene Discovery Technologies company information, Employees & Contact Information

We are excited to announce that we have rebranded to AURIGENE ONCOLOGY LIMITED. Please follow and contact us on our new page: https://www.linkedin.com/company/aurigene-oncology/

Company Details

Employees
511
Founded
-
Address
39-40, Kiadb Industrial Area, Electronic City Ph Ii,hosur Road,india
Phone
+91 40 4465 7438
Email
pr****@****ene.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bangalore, Karnataka
Looking for a particular Aurigene Discovery Technologies employee's phone or email?

Aurigene Discovery Technologies Questions

News

Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025 - Business Wire

Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025 Business Wire

Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models - Citeline News & Insights

Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models Citeline News & Insights

Aurigene Oncology divulges new CCR4 antagonists - BioWorld MedTech

Aurigene Oncology divulges new CCR4 antagonists BioWorld MedTech

Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies - Yahoo Finance

Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies Yahoo Finance

Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - PR Newswire

Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 PR Newswire

Akhil Ravi Appointed CEO of Aurigene Pharmaceutical Services Ltd - Pharmacy Times

Akhil Ravi Appointed CEO of Aurigene Pharmaceutical Services Ltd Pharmacy Times

Aurigene opens $40m Hyderabad biologics facility - BioProcess International

Aurigene opens $40m Hyderabad biologics facility BioProcess International

Aurigene opens new biologics facility in Hyderabad, India - Pharmaceutical Technology

Aurigene opens new biologics facility in Hyderabad, India Pharmaceutical Technology

Aurigene Pharmaceutical Services Opens Biologics Facility - Contract Pharma

Aurigene Pharmaceutical Services Opens Biologics Facility Contract Pharma

Structural and binding studies of cyclin‐dependent kinase 2 with NU6140 inhibitor - Wiley Online Library

Structural and binding studies of cyclin‐dependent kinase 2 with NU6140 inhibitor Wiley Online Library

Aurigene Pharmaceutical Services Limited, a global CRDMO, and Edity announce a strategic collaboration in cell therapy - PharmaLive

Aurigene Pharmaceutical Services Limited, a global CRDMO, and Edity announce a strategic collaboration in cell therapy PharmaLive

Expert Statement: Akhil Ravi, Aurigene Pharmaceutical Services - CHEManager

Expert Statement: Akhil Ravi, Aurigene Pharmaceutical Services CHEManager

Aurigene reports promising phase-1 data for its CAR-T therapy against myeloma - The Economic Times

Aurigene reports promising phase-1 data for its CAR-T therapy against myeloma The Economic Times

User - FinancialContent

User FinancialContent

Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene autoleucel - Times of India

Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene autoleucel Times of India

Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma - Business Wire

Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma Business Wire

Aurigene Oncology, Olema Pharmaceuticals identify KAT6A inhibitors - BioWorld MedTech

Aurigene Oncology, Olema Pharmaceuticals identify KAT6A inhibitors BioWorld MedTech

Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities - Business Wire

Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities Business Wire

Aurigene Pharmaceutical Services Ltd. introduces Aurigene.AI™, an artificial intelligence (AI) and machine learning (ML) assisted drug discovery platform - Business Wire

Aurigene Pharmaceutical Services Ltd. introduces Aurigene.AI™, an artificial intelligence (AI) and machine learning (ML) assisted drug discovery platform Business Wire

Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug - Business Wire

Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug Business Wire

Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated d - PharmiWeb.com

Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated d PharmiWeb.com

Dr Reddy’s R&D arm is now Aurigene Oncology - Times of India

Dr Reddy’s R&D arm is now Aurigene Oncology Times of India

Akhil Ravi appointed CEO of Aurigene Pharmaceutical Services Ltd. - PharmaLive

Akhil Ravi appointed CEO of Aurigene Pharmaceutical Services Ltd. PharmaLive

Aurigene Pharmaceutical Services to invest Rs 330 crore in Genome Valley - Deccan Chronicle

Aurigene Pharmaceutical Services to invest Rs 330 crore in Genome Valley Deccan Chronicle

Dr Reddy’s CRDMO arm Aurigene acquires 27% stake in CREL - Times of India

Dr Reddy’s CRDMO arm Aurigene acquires 27% stake in CREL Times of India

Silicon Valley - FinancialContent

Silicon Valley FinancialContent

Aurigene Pharmaceutical launches new biologics facility for developing Pre-clinical requisites at Hyderabad - ET HealthWorld

Aurigene Pharmaceutical launches new biologics facility for developing Pre-clinical requisites at Hyderabad ET HealthWorld

Aurigene Discovery Technologies Limited rebrands to Aurigene Oncology Limited with sharpened focus on cancer care - financialexpress.com

Aurigene Discovery Technologies Limited rebrands to Aurigene Oncology Limited with sharpened focus on cancer care financialexpress.com

Aurigene Pharma launches new database for accelerated hit identification - BioSpectrum India

Aurigene Pharma launches new database for accelerated hit identification BioSpectrum India

Dr Reddy's arm rolls AI&ML assisted drug discovery platform Aurigene.AI - Times of India

Dr Reddy's arm rolls AI&ML assisted drug discovery platform Aurigene.AI Times of India

Dr. Reddy’s arm Aurigene Oncology gets DCGI nod for Phase 2 trial for CAR-T cell therapy for multiple myeloma - The Hindu

Dr. Reddy’s arm Aurigene Oncology gets DCGI nod for Phase 2 trial for CAR-T cell therapy for multiple myeloma The Hindu

Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma - Express Pharma

Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma Express Pharma

Aurigene Pharma to set up facility with $40 million in Genome Valley - The Hindu

Aurigene Pharma to set up facility with $40 million in Genome Valley The Hindu

Aurigene rolls AI &ML-aided drug discovery platform - Times of India

Aurigene rolls AI &ML-aided drug discovery platform Times of India

Dr Reddy's arm Aurigene opens new biologics facility at Genome Valley in Hyderabad - Times of India

Dr Reddy's arm Aurigene opens new biologics facility at Genome Valley in Hyderabad Times of India

Aurigene to Present its CDK7 and KRAS Covalent Inhibitor Programs at AACR Annual Conference - PR Newswire UK

Aurigene to Present its CDK7 and KRAS Covalent Inhibitor Programs at AACR Annual Conference PR Newswire UK

Tushar Zade, CIO, CISO & CDO, Aurigene Pharmaceutical Services - Express Computer

Tushar Zade, CIO, CISO & CDO, Aurigene Pharmaceutical Services Express Computer

Aurigene Oncology stop clinical trials of skin disease drug: All you need to know - financialexpress.com

Aurigene Oncology stop clinical trials of skin disease drug: All you need to know financialexpress.com

Aurigene Pharmaceutical Services to set up $40 mn facility in Hyderabad - Moneycontrol

Aurigene Pharmaceutical Services to set up $40 mn facility in Hyderabad Moneycontrol

Exelixis, Dr Reddy's arm Aurigene ink pact - The Hans India

Exelixis, Dr Reddy's arm Aurigene ink pact The Hans India

Hyderabad: Aurigene Pharmaceuticals adopt African Lion at Nehru Zoological Park - Telangana Today

Hyderabad: Aurigene Pharmaceuticals adopt African Lion at Nehru Zoological Park Telangana Today

Top Aurigene Discovery Technologies Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant